These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 20020127)
1. The role of chemokines in B cell chronic lymphocytic leukaemia: pathophysiological aspects and clinical impact. Schröttner P; Leick M; Burger M Ann Hematol; 2010 May; 89(5):437-46. PubMed ID: 20020127 [TBL] [Abstract][Full Text] [Related]
2. Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow. Hartmann TN; Grabovsky V; Wang W; Desch P; Rubenzer G; Wollner S; Binsky I; Vallon-Eberhard A; Sapoznikov A; Burger M; Shachar I; Haran M; Honczarenko M; Greil R; Alon R Cancer Res; 2009 Apr; 69(7):3121-30. PubMed ID: 19293181 [TBL] [Abstract][Full Text] [Related]
3. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773 [TBL] [Abstract][Full Text] [Related]
4. Chronic lymphocytic leukemia: insights from lymph nodes & bone marrow and clinical perspectives. Jaksić O; Kardum-Skelin I; Jaksić B Coll Antropol; 2010 Mar; 34(1):309-13. PubMed ID: 20432765 [TBL] [Abstract][Full Text] [Related]
5. Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia. Alfonso-Pérez M; López-Giral S; Quintana NE; Loscertales J; Martín-Jiménez P; Muñoz C J Leukoc Biol; 2006 Jun; 79(6):1157-65. PubMed ID: 16603585 [TBL] [Abstract][Full Text] [Related]
6. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival. Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907 [TBL] [Abstract][Full Text] [Related]
7. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases]. Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412 [TBL] [Abstract][Full Text] [Related]
8. High endothelial venules and cell adhesion molecules in B-cell chronic lymphocytic leukaemia and related low grade B-cell lymphoma/leukaemia: I. High endothelial venules and lymphocyte migration. Csanaky G Histol Histopathol; 1994 Jul; 9(3):571-5. PubMed ID: 7981503 [TBL] [Abstract][Full Text] [Related]
9. High endothelial venules and cell adhesion molecules in B-cell chronic lymphocytic leukaemia and related low grade B-cell lymphoma/leukaemia: II. Expression of cell adhesion molecules in lymph nodes biopsies. Csanaky G Histol Histopathol; 1994 Jul; 9(3):577-82. PubMed ID: 7526911 [TBL] [Abstract][Full Text] [Related]
10. ZAP-70 protein expression and CD38 positivity in B-cell chronic lymphocytic leukemia. Ertault-Daneshpouy M; Noguera ME; Gisselbrecht C; Haddad A; Brice P; Marolleau JP; Soulier J; Mounier N Clin Adv Hematol Oncol; 2008 Jan; 6(1):55-63. PubMed ID: 18322442 [TBL] [Abstract][Full Text] [Related]
11. PEG10 activation by co-stimulation of CXCR5 and CCR7 essentially contributes to resistance to apoptosis in CD19+CD34+ B cells from patients with B cell lineage acute and chronic lymphocytic leukemia. Hu C; Xiong J; Zhang L; Huang B; Zhang Q; Li Q; Yang M; Wu Y; Wu Q; Shen Q; Gao Q; Zhang K; Sun Z; Liu J; Jin Y; Tan J Cell Mol Immunol; 2004 Aug; 1(4):280-94. PubMed ID: 16225771 [TBL] [Abstract][Full Text] [Related]
12. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Shanafelt TD; Kay NE Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064 [TBL] [Abstract][Full Text] [Related]
13. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells. De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639 [TBL] [Abstract][Full Text] [Related]
14. Transendothelial migration of lymphocytes in chronic lymphocytic leukaemia is impaired and involved down-regulation of both L-selectin and CD23. Chen JR; Gu BJ; Dao LP; Bradley CJ; Mulligan SP; Wiley JS Br J Haematol; 1999 Apr; 105(1):181-9. PubMed ID: 10233382 [TBL] [Abstract][Full Text] [Related]
15. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Ebert LM; Schaerli P; Moser B Mol Immunol; 2005 May; 42(7):799-809. PubMed ID: 15829268 [TBL] [Abstract][Full Text] [Related]
16. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. Ghia P; Chiorazzi N; Stamatopoulos K J Intern Med; 2008 Dec; 264(6):549-62. PubMed ID: 19017179 [TBL] [Abstract][Full Text] [Related]
17. Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update. Molica S; De Rossi G; Luciani M; Levato D Haematologica; 1995; 80(2):176-93. PubMed ID: 7628755 [TBL] [Abstract][Full Text] [Related]
18. HLA-G in B-chronic lymphocytic leukaemia: clinical relevance and functional implications. Rebmann V; Nückel H; Dührsen U; Grosse-Wilde H Semin Cancer Biol; 2007 Dec; 17(6):430-5. PubMed ID: 17683947 [TBL] [Abstract][Full Text] [Related]
19. Intracellular IFN-gamma expression by CD3+/CD8+ cell subset in B-CLL patients correlates with stage of the disease. Podhorecka M; Dmoszynska A; Rolinski J Eur J Haematol; 2004 Jul; 73(1):29-35. PubMed ID: 15182335 [TBL] [Abstract][Full Text] [Related]